OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: OCTINOXATE 7.0% [] TITANIUM DIOXIDE 0.98%
ACTIVE INGREDIENTS: OCTINOXATE 7.0% [] TITANIUM DIOXIDE 0.98%
USAGE: DAB A SMALL AMOUNT DIRECTLY ONTO SPOT WITH PRECISION APPLICATOR. BLEND INTO SKIN WITH A BRUSH.
WARNING: KEEP OUT OF EYES. STOP USE IF IRRITATION OCCURS. KEEP OUT OF REACH OF CHILDREN.
PRINCIPAL DISPLAY PANEL:
BOBBI BROWN
BRIGHTENING
SPOT
TREATMENT
CORRECTOR
SPF 25
0.16 OZ/ 4.5 ML
BOBBI BROWN PROFESSIONAL COSMETICS INC
600 MADISON AVE
NEW YORK, NY 10022
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64141-003-01 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-cb9d-621f-e053-dbdaa90a74ad | 25092818-0aaa-482d-9c45-04bd4e8ddf2e |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64141-003-01 | BRIGHTENING SPOT TREATMENT CORRECTORSPF 25 | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 64141-003-02 | BRIGHTENING SPOT TREATMENT CORRECTORSPF 25 | 4.5 mL in 1 TUBE, WITH APPLICATOR | CREAM | 4.5 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 64141-003 | 64141-003-02, 64141-003-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d115cd2a-4994-463b-8fe5-cb0887fee26a | 25092818-0aaa-482d-9c45-04bd4e8ddf2e | 2010-04-19 | Warnings | d115cd2a-4994-463b-8fe5-cb0887fee26a 25092818-0aaa-482d-9c45-04bd4e8ddf2e |
Adverse event summaries are temporarily unavailable. Other product information remains available.